We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Pharmanutra SpA (PHN) NPV

Sell:€48.70 Buy:€48.85 Change: €0.30 (0.61%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:€48.70
Buy:€48.85
Change: €0.30 (0.61%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:€48.70
Buy:€48.85
Change: €0.30 (0.61%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Pharmanutra SpA is an Italy-based company engaged in the healthcare industry. The Company develops nutraceutical products and medical devices. It focuses on studying and producing formulations that are backed up in scientific research. It is able to cover all stages of the development of a product, from its design, formulation and registration to its marketing, distribution and training of its commercial representatives. The Company offers Gestalys DHA, a nutritional supplement; Cetilar, a massage coadiuvant, improves and brings relief to joints affected by osteoarthritis; Cetilar patch, a transdermic patch containing a concentrated formulation of cetylated fatty acids (CFA) esters; SiderAL Forte; CardioSiderAL; SiderAL Folico; SiderAL; Bonecal and Novomega, among others.

Contact details

Address:
Via delle Lenze n. 216/B
PISA
56122
Italy
Telephone:
+ ()
Website:
https://www.pharmanutra.it/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
PHN
ISIN:
IT0005274094
Market cap:
€475.34 million
Shares in issue:
9.61 million
Sector:
Personal Care Products
Exchange:
Milan Stock Exchange
Country:
Italy
Currency:
Euro
Indices:
n/a

Key personnel

  • Andrea Lacorte
    Executive Chairman of the Board
  • Roberto Lacorte
    Executive Vice Chairman of the Board
  • Carlo Volpi
    Chief Marketing Officer, Executive Director
  • Germano Tarantino
    Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.